Nephros, Inc. (NEPH) is currently waiting on two FDA approvals for two
hemodiafiltration devices (which could happen any day this week).
These two approvals should happen on the same day. They have already
received approval from the FDA for one device earlier last month. As
of right now, the FDA has approved EVERY device application that has
come across their desks this year. This is as sure of a thing as  you
can get.

Friday saw a 15.12% gain as people rushed to get in before the
inevitable approval of these two medical devices. Monday saw a 2.36%
gain at $1.52. Tuesday saw a 8.55% gain at $1.65 The rest of this week
should see some similar gains until the approvals are announced. Hurry
up and get in before it is too late.